Global Hepatitis Drugs Market Size, Status and Forecast 2025

February 2018 | 101 pages | ID: GC64CB64EEAEN
QYResearch

Abstracts

This report studies the global Hepatitis Drugs market, analyzes and researches the Hepatitis Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• GlaxoSmithKline
• Johnson & Johnson
• Merck
• Novartis
• F. Hoffmann-La Roche
• Arbutus Biopharma
• Janssen Pharmaceuticals
• Bristol-Myers Squibb
• Gilead Sciences
• Vertex Pharmaceuticals
• Abbvie
• Achillion Pharmaceuticals
• Dynavax Technologies
• Mitsubishi Tanabe Pharma

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• Oral
• Injection

Market segment by Application, Hepatitis Drugs can be split into

• Hospitals
• Clinics
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Hepatitis Drugs Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF HEPATITIS DRUGS

1.1 Hepatitis Drugs Market Overview
  1.1.1 Hepatitis Drugs Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Hepatitis Drugs Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Hepatitis Drugs Market by Type
  1.3.1 Oral
  1.3.2 Injection
1.4 Hepatitis Drugs Market by End Users/Application
  1.4.1 Hospitals
  1.4.2 Clinics
  1.4.3 Other

2 GLOBAL HEPATITIS DRUGS COMPETITION ANALYSIS BY PLAYERS

2.1 Hepatitis Drugs Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 GlaxoSmithKline
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Hepatitis Drugs Revenue (Million USD) (2013-2018)
  3.1.5 Recent Developments
3.2 Johnson & Johnson
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Hepatitis Drugs Revenue (Million USD) (2013-2018)
  3.2.5 Recent Developments
3.3 Merck
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Hepatitis Drugs Revenue (Million USD) (2013-2018)
  3.3.5 Recent Developments
3.4 Novartis
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Hepatitis Drugs Revenue (Million USD) (2013-2018)
  3.4.5 Recent Developments
3.5 F. Hoffmann-La Roche
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Hepatitis Drugs Revenue (Million USD) (2013-2018)
  3.5.5 Recent Developments
3.6 Arbutus Biopharma
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Hepatitis Drugs Revenue (Million USD) (2013-2018)
  3.6.5 Recent Developments
3.7 Janssen Pharmaceuticals
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Hepatitis Drugs Revenue (Million USD) (2013-2018)
  3.7.5 Recent Developments
3.8 Bristol-Myers Squibb
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Hepatitis Drugs Revenue (Million USD) (2013-2018)
  3.8.5 Recent Developments
3.9 Gilead Sciences
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Hepatitis Drugs Revenue (Million USD) (2013-2018)
  3.9.5 Recent Developments
3.10 Vertex Pharmaceuticals
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Hepatitis Drugs Revenue (Million USD) (2013-2018)
  3.10.5 Recent Developments
3.11 Abbvie
3.12 Achillion Pharmaceuticals
3.13 Dynavax Technologies
3.14 Mitsubishi Tanabe Pharma

4 GLOBAL HEPATITIS DRUGS MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Hepatitis Drugs Market Size by Type (2013-2018)
4.2 Global Hepatitis Drugs Market Size by Application (2013-2018)
4.3 Potential Application of Hepatitis Drugs in Future
4.4 Top Consumer/End Users of Hepatitis Drugs

5 UNITED STATES HEPATITIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Hepatitis Drugs Market Size (2013-2018)
5.2 United States Hepatitis Drugs Market Size and Market Share by Players (2013-2018)
5.3 United States Hepatitis Drugs Market Size by Application (2013-2018)

6 EU HEPATITIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Hepatitis Drugs Market Size (2013-2018)
6.2 EU Hepatitis Drugs Market Size and Market Share by Players (2013-2018)
6.3 EU Hepatitis Drugs Market Size by Application (2013-2018)

7 JAPAN HEPATITIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Hepatitis Drugs Market Size (2013-2018)
7.2 Japan Hepatitis Drugs Market Size and Market Share by Players (2013-2018)
7.3 Japan Hepatitis Drugs Market Size by Application (2013-2018)

8 CHINA HEPATITIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Hepatitis Drugs Market Size (2013-2018)
8.2 China Hepatitis Drugs Market Size and Market Share by Players (2013-2018)
8.3 China Hepatitis Drugs Market Size by Application (2013-2018)

9 INDIA HEPATITIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Hepatitis Drugs Market Size (2013-2018)
9.2 India Hepatitis Drugs Market Size and Market Share by Players (2013-2018)
9.3 India Hepatitis Drugs Market Size by Application (2013-2018)

10 SOUTHEAST ASIA HEPATITIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Hepatitis Drugs Market Size (2013-2018)
10.2 Southeast Asia Hepatitis Drugs Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Hepatitis Drugs Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Hepatitis Drugs Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Hepatitis Drugs Revenue and Growth Rate (2018-2025)
  11.1.2 EU Hepatitis Drugs Revenue and Growth Rate (2018-2025)
  11.1.3 Japan Hepatitis Drugs Revenue and Growth Rate (2018-2025)
  11.1.4 China Hepatitis Drugs Revenue and Growth Rate (2018-2025)
  11.1.5 India Hepatitis Drugs Revenue and Growth Rate (2018-2025)
  11.1.6 Southeast Asia Hepatitis Drugs Revenue and Growth Rate (2018-2025)
11.2 Global Hepatitis Drugs Market Size (Value) by Type (2018-2025)
11.3 Global Hepatitis Drugs Market Size by Application (2018-2025)

12 HEPATITIS DRUGS MARKET DYNAMICS

12.1 Hepatitis Drugs Market Opportunities
12.2 Hepatitis Drugs Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Hepatitis Drugs Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Hepatitis Drugs Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global Hepatitis Drugs Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Hepatitis Drugs Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Hepatitis Drugs Market Share by Regions (2013-2018)
Figure United States Hepatitis Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Hepatitis Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Hepatitis Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Hepatitis Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Hepatitis Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Hepatitis Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Hepatitis Drugs Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Hepatitis Drugs Revenue Market Share by Type in 2017
Figure Oral Market Size (Million USD) and Growth Rate (2013-2018)
Figure Injection Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Hepatitis Drugs Market Share by Application in 2017
Figure Hepatitis Drugs Market Size (Million USD) and Growth Rate in Hospitals (2013-2018)
Figure Hepatitis Drugs Market Size (Million USD) and Growth Rate in Clinics (2013-2018)
Figure Hepatitis Drugs Market Size (Million USD) and Growth Rate in Other (2013-2018)
Table Hepatitis Drugs Market Size (Million USD) by Players (2013-2018)
Figure Hepatitis Drugs Market Size Share by Players in 2013
Figure Hepatitis Drugs Market Size Share by Players in 2017
Table GlaxoSmithKline Basic Information List
Table Hepatitis Drugs Business Revenue (Million USD) of GlaxoSmithKline (2013-2018)
Figure GlaxoSmithKline Hepatitis Drugs Business Revenue Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Hepatitis Drugs Business Revenue (Million USD) of Johnson & Johnson (2013-2018)
Figure Johnson & Johnson Hepatitis Drugs Business Revenue Market Share (2013-2018)
Table Merck Basic Information List
Table Hepatitis Drugs Business Revenue (Million USD) of Merck (2013-2018)
Figure Merck Hepatitis Drugs Business Revenue Market Share (2013-2018)
Table Novartis Basic Information List
Table Hepatitis Drugs Business Revenue (Million USD) of Novartis (2013-2018)
Figure Novartis Hepatitis Drugs Business Revenue Market Share (2013-2018)
Table F. Hoffmann-La Roche Basic Information List
Table Hepatitis Drugs Business Revenue (Million USD) of F. Hoffmann-La Roche (2013-2018)
Figure F. Hoffmann-La Roche Hepatitis Drugs Business Revenue Market Share (2013-2018)
Table Arbutus Biopharma Basic Information List
Table Hepatitis Drugs Business Revenue (Million USD) of Arbutus Biopharma (2013-2018)
Figure Arbutus Biopharma Hepatitis Drugs Business Revenue Market Share (2013-2018)
Table Janssen Pharmaceuticals Basic Information List
Table Hepatitis Drugs Business Revenue (Million USD) of Janssen Pharmaceuticals (2013-2018)
Figure Janssen Pharmaceuticals Hepatitis Drugs Business Revenue Market Share (2013-2018)
Table Bristol-Myers Squibb Basic Information List
Table Hepatitis Drugs Business Revenue (Million USD) of Bristol-Myers Squibb (2013-2018)
Figure Bristol-Myers Squibb Hepatitis Drugs Business Revenue Market Share (2013-2018)
Table Gilead Sciences Basic Information List
Table Hepatitis Drugs Business Revenue (Million USD) of Gilead Sciences (2013-2018)
Figure Gilead Sciences Hepatitis Drugs Business Revenue Market Share (2013-2018)
Table Vertex Pharmaceuticals Basic Information List
Table Hepatitis Drugs Business Revenue (Million USD) of Vertex Pharmaceuticals (2013-2018)
Figure Vertex Pharmaceuticals Hepatitis Drugs Business Revenue Market Share (2013-2018)
Table Abbvie Basic Information List
Table Hepatitis Drugs Business Revenue (Million USD) of Abbvie (2013-2018)
Figure Abbvie Hepatitis Drugs Business Revenue Market Share (2013-2018)
Table Achillion Pharmaceuticals Basic Information List
Table Hepatitis Drugs Business Revenue (Million USD) of Achillion Pharmaceuticals (2013-2018)
Figure Achillion Pharmaceuticals Hepatitis Drugs Business Revenue Market Share (2013-2018)
Table Dynavax Technologies Basic Information List
Table Hepatitis Drugs Business Revenue (Million USD) of Dynavax Technologies (2013-2018)
Figure Dynavax Technologies Hepatitis Drugs Business Revenue Market Share (2013-2018)
Table Mitsubishi Tanabe Pharma Basic Information List
Table Hepatitis Drugs Business Revenue (Million USD) of Mitsubishi Tanabe Pharma (2013-2018)
Figure Mitsubishi Tanabe Pharma Hepatitis Drugs Business Revenue Market Share (2013-2018)
Table Global Hepatitis Drugs Market Size (Million USD) by Product (2013-2018)
Figure Global Hepatitis Drugs Revenue Market Share (%) by Product (2013-2018)
Figure Global Hepatitis Drugs Market Share by Product in 2017
Table Global Hepatitis Drugs Market Size by Application (2013-2018)
Figure Global Hepatitis Drugs Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Hepatitis Drugs
Figure United States Hepatitis Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Hepatitis Drugs Market Size (Million USD) by Players (2013-2018)
Figure United States Hepatitis Drugs Market Size Share by Players in 2013
Figure United States Hepatitis Drugs Market Size Share by Players in 2017
Table United States Hepatitis Drugs Market Size by Application (2013-2018)
Figure United States Hepatitis Drugs Revenue Market Share (%) by Application (2013-2018)
Figure United States Hepatitis Drugs Market Size Share by Application in 2017
Figure EU Hepatitis Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table EU Hepatitis Drugs Market Size (Million USD) by Players (2013-2018)
Figure EU Hepatitis Drugs Market Size Share by Players in 2013
Figure EU Hepatitis Drugs Market Size Share by Players in 2017
Table EU Hepatitis Drugs Market Size by Application (2013-2018)
Figure EU Hepatitis Drugs Revenue Market Share (%) by Application (2013-2018)
Figure EU Hepatitis Drugs Market Size Share by Application in 2017
Figure Japan Hepatitis Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Hepatitis Drugs Market Size (Million USD) by Players (2013-2018)
Figure Japan Hepatitis Drugs Market Size Share by Players in 2013
Figure Japan Hepatitis Drugs Market Size Share by Players in 2017
Table Japan Hepatitis Drugs Market Size by Application (2013-2018)
Figure Japan Hepatitis Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Japan Hepatitis Drugs Market Size Share by Application in 2017
Figure China Hepatitis Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table China Hepatitis Drugs Market Size (Million USD) by Players (2013-2018)
Figure China Hepatitis Drugs Market Size Share by Players in 2013
Figure China Hepatitis Drugs Market Size Share by Players in 2017
Table China Hepatitis Drugs Market Size by Application (2013-2018)
Figure China Hepatitis Drugs Revenue Market Share (%) by Application (2013-2018)
Figure China Hepatitis Drugs Market Size Share by Application in 2017
Figure India Hepatitis Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table India Hepatitis Drugs Market Size (Million USD) by Players (2013-2018)
Figure India Hepatitis Drugs Market Size Share by Players in 2013
Figure India Hepatitis Drugs Market Size Share by Players in 2017
Table India Hepatitis Drugs Market Size by Application (2013-2018)
Figure India Hepatitis Drugs Revenue Market Share (%) by Application (2013-2018)
Figure India Hepatitis Drugs Market Size Share by Application in 2017
Figure Southeast Asia Hepatitis Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Hepatitis Drugs Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Hepatitis Drugs Market Size Share by Players in 2013
Figure Southeast Asia Hepatitis Drugs Market Size Share by Players in 2017
Table Southeast Asia Hepatitis Drugs Market Size by Application (2013-2018)
Figure Southeast Asia Hepatitis Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Hepatitis Drugs Market Size Share by Application in 2017
Figure Global Hepatitis Drugs Market Size and Growth Rate (2018-2025)
Table Global Hepatitis Drugs Market Size (Million USD) by Regions (2018-2025)
Figure Global Hepatitis Drugs Market Size Share (2018-2025)
Figure Global Hepatitis Drugs Market Size Share by Regions in 2025
Figure United States Hepatitis Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Hepatitis Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Hepatitis Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Hepatitis Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Hepatitis Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Hepatitis Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Hepatitis Drugs Market Size (Million USD) by Type (2018-2025)
Figure Global Hepatitis Drugs Market Size Share by Type in 2018
Figure Global Hepatitis Drugs Market Size Share by Type in 2025
Table Global Hepatitis Drugs Market Size (Million USD) by Application (2018-2025)
Figure Global Hepatitis Drugs Market Size (Million USD) by Application in 2018
Figure Global Hepatitis Drugs Market Size (Million USD) by Application in 2025